F-1/A: Meiwu Technology Plans Dual Offering of 60 Million Ordinary Shares

Meiwu Technology Company Limited intends to raise capital through a primary offering and a selling shareholder offering, each involving 30 million ordinary shares.

Summary

• Meiwu Technology Company Limited is planning a best-efforts offering of up to 30,000,000 ordinary shares.
• A selling shareholder, Changbin Xia, also intends to offer 30,000,000 ordinary shares.
• Mr. Xia purchased his shares at $0.80 per share on October 22, 2024.
• The company will not receive any proceeds from the sale of shares by the selling shareholder.
• The company intends to use the net proceeds from the primary offering for recruitment, online platform upgrades, distribution network expansion, and marketing for its planned functional skincare business.
• The company's ordinary shares are listed on Nasdaq under the symbol WNW, with a last reported sale price of $0.80 on October 23, 2024.
• Meiwu Technology is a British Virgin Islands holding company with operations conducted by subsidiaries in China through a VIE structure, which involves unique risks to investors.
• The VIE agreements have not been tested in a court of law in China.
• Chinese regulatory authorities could disallow the VIE structure, which would likely result in a material change in operations and a material decline in the value of the company's securities.
• The company is subject to legal and operational risks associated with being based in China, including uncertainties in the interpretation and enforcement of PRC laws and regulations.
• The company's ordinary shares may be delisted under the Holding Foreign Companies Accountable Act if the PCAOB is unable to inspect the company's auditor.
• The company's current auditor, Enrome LLP, is headquartered in Singapore and is subject to PCAOB inspections.
• The company is a foreign private issuer and is subject to reduced public company reporting requirements.
• Investing in the company's ordinary shares involves a high degree of risk, including the risk of losing the entire investment.

Sentiment

Score: 4

Explanation: The document presents a mixed sentiment. While there's a potential for growth with the new skincare business and the capital raise, the risks associated with the VIE structure, Chinese regulations, and potential delisting weigh heavily on the overall outlook.

Positives

• The company intends to use the net proceeds from the primary offering for recruitment, online platform upgrades, distribution network expansion, and marketing for its planned functional skincare business.
• The company's current auditor, Enrome LLP, is headquartered in Singapore and is subject to PCAOB inspections.

Negatives

• Meiwu Technology is a British Virgin Islands holding company with operations conducted by subsidiaries in China through a VIE structure, which involves unique risks to investors.
• The VIE agreements have not been tested in a court of law in China.
• Chinese regulatory authorities could disallow the VIE structure, which would likely result in a material change in operations and a material decline in the value of the company's securities.
• The company is subject to legal and operational risks associated with being based in China, including uncertainties in the interpretation and enforcement of PRC laws and regulations.
• The company's ordinary shares may be delisted under the Holding Foreign Companies Accountable Act if the PCAOB is unable to inspect the company's auditor.
• The company is a foreign private issuer and is subject to reduced public company reporting requirements.
• Investing in the company's ordinary shares involves a high degree of risk, including the risk of losing the entire investment.

Risks

• The Chinese government may intervene or influence the company's operations.
• Investors who buy Ordinary Shares at different times will likely pay different prices.
• The management team will have broad discretion over the use of the net proceeds from the offering.
• The company will operate in a dynamic industry and has a limited operating history.
• The company will rely on the formulas provided by third-party manufacturers.
• The beauty industry is highly competitive.
• The company's success will be dependent on the popularity of its products and its ability to anticipate and respond to changes in industry trends and consumer preferences and behavior in a timely manner.
• The company's new product introductions may not be as successful as anticipated.
• The company's business will depend, in part, on the quality, effectiveness and safety of its products.
• The company may not be able to successfully implement its growth strategy.
• If the company is unable to provide superior customer experiences, its business and reputation may be materially and adversely affected.
• The company's reliance on distributors, retailers and other third-parties could affect its ability to efficiently and profitably distribute and market its products.
• The company's operating results could be materially harmed if it is unable to accurately forecast consumer demand for its products or adequately manage its inventory.
• The company will rely on third-party service providers for logistics services.
• The company's delivery, return and exchange policies may adversely affect its results of operations.
• Failure to lease suitable warehouse facilities or any interruption in the operation of the warehouse for an extended period may negatively affect the business and results of operations.
• The company may be subject to infringement claims of intellectual property rights or other rights of third parties.
• If the company is unable to protect its intellectual property, the value of its brands and other intangible assets may be diminished.
• The company is exposed to the risks of an economic recession, credit and capital markets volatility and economic and financial crisis as a result of the COVID-19 virus pandemic.
• If the company is not able to implement its strategies to achieve its business objectives, its business operations and financial performance will be adversely affected.
• The company depends on third parties to supply its food products; any adverse changes in such supply or the costs of products may adversely affect its operations.
• Higher labor costs could adversely affect the company's business and financial results.
• Health concerns or adverse developments with respect to the safety or quality of the food product industry in general or the company's own products specifically may damage its reputation.
• The approval of the China Securities Regulatory Commission and other compliance procedures may be required in connection with the offering of the company's securities in the U.S.
• Uncertainties in the interpretation and enforcement of PRC laws and regulations and changes in policies, rules, and regulations in China could limit the legal protection available to you and us.
• The company relies on the VIE Agreements for a portion of its business operations, which may not be as effective as direct ownership in providing operational control.
• The shareholders of the VIE may have potential conflicts of interest with the company, which may materially and adversely affect its business and financial condition.
• The VIE Agreement may be subject to scrutiny by the PRC tax authorities and they may determine that the company or the VIE owe additional taxes.
• The company may lose the ability to use and benefit from assets held by the VIE that are material to the operation of its business if the entity goes bankrupt or becomes subject to a dissolution or liquidation proceeding.
• If the chops of WFOE, the company's PRC subsidiaries and the VIE, are not kept safely, are stolen or are used by unauthorized persons or for unauthorized purposes, the corporate governance of these entities could be severely and adversely compromised.
• Uncertainties in the interpretation and enforcement of Chinese laws and regulations could limit the legal protections available to us.
• The company may have difficulty in enforcing any rights it may have under the VIE Agreements in PRC.
• The company relies on dividends and other distributions on equity paid by its PRC subsidiaries to fund any cash and financing requirements it may have.
• Fluctuations in exchange rates could have a material adverse effect on the company's results of operations and the price of its shares.
• Governmental control of currency conversion may limit the company's ability to utilize its net revenues effectively and affect the value of your investment.
• Failure to make adequate contributions to various employee benefit plans as required by PRC regulations may subject the company to penalties.
• The M&A Rules and certain other PRC regulations establish complex procedures for some acquisitions of Chinese companies by foreign investors.
• PRC regulations relating to offshore investment activities by PRC residents may limit the company's PRC subsidiaries ability to increase their registered capital or distribute profits to us.
• If the company is classified as a PRC resident enterprise for PRC income tax purposes, such classification could result in unfavorable tax consequences to us and our non-PRC shareholders.
• The company may not be able to obtain certain benefits under relevant tax treaty on dividends paid by its PRC subsidiaries to us through our Hong Kong subsidiary.
• Enhanced scrutiny over acquisition transactions by the PRC tax authorities may have a negative impact on potential acquisitions we may pursue in the future.
• The company will incur additional costs as a result of becoming a public company.
• The obligation to disclose information publicly may put the company at a disadvantage to competitors that are private companies.
• The company is a foreign private issuer, and its disclosure obligations differ from those of U.S. domestic reporting companies.
• The company is an emerging growth company, and we cannot be certain if the reduced reporting requirements applicable to emerging growth companies will make our Ordinary Shares less attractive to investors.

Future Outlook

The company plans to use the net proceeds from the primary offering for recruitment, online platform upgrades, distribution network expansion, and marketing for its planned functional skincare business.

Industry Context

The document relates to the broader trend of Chinese companies seeking capital in overseas markets, while navigating increasing regulatory scrutiny from both Chinese and U.S. authorities.

Comparison to Industry Standards

• The VIE structure is a common practice for Chinese companies seeking foreign investment in restricted sectors, but it carries inherent risks.
• Comparable companies using VIE structures include Alibaba and Baidu, which have faced similar regulatory challenges.
• The Holding Foreign Companies Accountable Act impacts numerous China-based companies listed on U.S. exchanges, creating uncertainty for investors.

Stakeholder Impact

• Shareholders face significant risks, including potential delisting and regulatory changes.
• Employees may be affected by the company's ability to operate in China and implement its business plan.
• Customers may benefit from the planned functional skincare business.

Next Steps

• The company needs to successfully execute its functional skincare business plan.
• The company needs to navigate the complex regulatory environment in China.
• The company needs to maintain compliance with Nasdaq listing requirements and PCAOB inspection standards.

Key Dates

Keywords

Ordinary Shares, VIE structure, China, PCAOB, HFCAA, Offering, Functional Skincare, Meiwu Technology